| Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis F Ceban, S Ling, LMW Lui, Y Lee, H Gill, KM Teopiz, NB Rodrigues, ... Brain, behavior, and immunity 101, 93-135, 2022 | 1060 | 2022 |
| Onset and frequency of depression in post-COVID-19 syndrome: A systematic review O Renaud-Charest, LMW Lui, S Eskander, F Ceban, R Ho, ... Journal of psychiatric research 144, 129-137, 2021 | 308 | 2021 |
| Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis F Ceban, D Nogo, IP Carvalho, Y Lee, F Nasri, J Xiong, LMW Lui, ... JAMA psychiatry 78 (10), 1079-1091, 2021 | 192 | 2021 |
| Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis Y Alnefeesi, D Chen-Li, E Krane, MY Jawad, NB Rodrigues, F Ceban, ... Journal of psychiatric research 151, 693-709, 2022 | 104 | 2022 |
| Molecular mechanisms of psilocybin and implications for the treatment of depression S Ling, F Ceban, LMW Lui, Y Lee, KM Teopiz, NB Rodrigues, O Lipsitz, ... CNS drugs 36 (1), 17-30, 2022 | 74 | 2022 |
| Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research F Ceban, A Leber, MY Jawad, M Yu, LMW Lui, M Subramaniapillai, ... Infectious Diseases 54 (7), 467-477, 2022 | 61 | 2022 |
| Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: a systematic review and meta-analysis YK Liu, S Ling, LMW Lui, F Ceban, M Vinberg, LV Kessing, RC Ho, ... Journal of affective disorders 300, 449-461, 2022 | 48 | 2022 |
| Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders F Ceban, JD Rosenblat, K Kratiuk, Y Lee, NB Rodrigues, H Gill, ... CNS drugs 35 (9), 925-934, 2021 | 48 | 2021 |
| Deficits of social cognition in bipolar disorder: Systematic review and meta‐analysis ES Gillissie, LMW Lui, F Ceban, K Miskowiak, S Gok, B Cao, KM Teopiz, ... Bipolar Disorders 24 (2), 137-148, 2022 | 42 | 2022 |
| COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis F Ceban, D Kulzhabayeva, NB Rodrigues, JD Di Vincenzo, H Gill, ... Brain, behavior, and immunity 111, 211-229, 2023 | 34 | 2023 |
| Active mechanisms of ketamine-assisted psychotherapy: a systematic review I Joneborg, Y Lee, JD Di Vincenzo, F Ceban, S Meshkat, LMW Lui, ... Journal of Affective Disorders 315, 105-112, 2022 | 33 | 2022 |
| Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis S Meshkat, Y Alnefeesi, MY Jawad, JD Di Vincenzo, NB Rodrigues, ... Psychiatry research 317, 114857, 2022 | 32 | 2022 |
| The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits D Nogo, AK Jasrai, H Kim, F Nasri, F Ceban, LMW Lui, JD Rosenblat, ... Psychopharmacology 239 (7), 2011-2039, 2022 | 31 | 2022 |
| The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review A Mckenzie, S Meshkat, LMW Lui, R Ho, JD Di Vincenzo, F Ceban, B Cao, ... Journal of Psychiatric Research 149, 252-259, 2022 | 22 | 2022 |
| Pharmacogenomics of ketamine: A systematic review S Meshkat, NB Rodrigues, JD Di Vincenzo, F Ceban, S Jaberi, ... Journal of Psychiatric Research 145, 27-34, 2022 | 22 | 2022 |
| Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review Y Alnefeesi, JK Tamura, LMW Lui, MY Jawad, F Ceban, S Ling, F Nasri, ... Neuroscience & Biobehavioral Reviews 131, 192-210, 2021 | 22 | 2021 |
| The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis MY Jawad, JD Di Vincenzo, F Ceban, S Jaberi, LMW Lui, ES Gillissie, ... Expert opinion on drug safety 21 (6), 841-852, 2022 | 21 | 2022 |
| The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression MY Jawad, JD Di Vincenzo, S Badulescu, KM Teopiz, A Tabassum, ... Neuropharmacology 223, 109299, 2023 | 18 | 2023 |
| Immune response to vaccination in adults with mental disorders: a systematic review K Xiao, ES Gillissie, LMW Lui, F Ceban, KM Teopiz, H Gill, B Cao, R Ho, ... Journal of affective disorders 304, 66-77, 2022 | 17 | 2022 |
| Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial RS McIntyre, L Phan, ATH Kwan, RB Mansur, JD Rosenblat, Z Guo, ... Brain 147 (3), 849-857, 2024 | 16 | 2024 |
Joshua RosenblatUniversity of Toronto在 utoronto.ca 的电子邮件经过验证
